High-Density Lipoprotein (HDL) Modulation and Endothelial Function

NCT00150722 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: atorvastatin (or other tolerated statin + Niaspan/placebo)

Sponsor

University of Calgary

Collaborators

[object Object]